These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 865381)

  • 21. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.
    Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C
    Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity of purified chick embryo cell anti-rabies vaccine in post-exposure treatment of animal bite cases.
    Bhardwaj M; Bhattacharya D; Chhabra M; Ichhpujani RL
    J Commun Dis; 2002 Mar; 34(1):40-2. PubMed ID: 12718340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intradermal simulated rabies postexposure prophylaxis using purified chick embryo rabies vaccine.
    Charanasri U; Meesomboon V; Kingnate D; Samuthananont P; Chaeychomsri W
    J Med Assoc Thai; 1994 Mar; 77(3):157-60. PubMed ID: 7798851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative evaluation of immunogenicity, reactogenecity and safety of purified chick embryo cell rabies vaccine and neural tissue rabies vaccine.
    Deshpande AK; Londhe VA; Akarte S; Briggs D
    J Assoc Physicians India; 2003 Jul; 51():655-8. PubMed ID: 14621031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical evaluation of purified vero-cell rabies vaccine in patients bitten by rabid animals in India.
    Sehgal S; Bhattacharya D; Bhardwaj M
    J Commun Dis; 1994 Sep; 26(3):139-46. PubMed ID: 7868836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serovaccination by human immune globulin and HDCS-vaccine against rabies.
    Kuwert EK; Werner J; Marcus I; Cabasso VJ
    Dev Biol Stand; 1978; 40():129-36. PubMed ID: 680386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on clinical trials and immune effect of a new purified rabies vaccine prepared from Vero cells.
    Dong G; Zheng H; Liu Z
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Mar; 14(1):19-23. PubMed ID: 11503018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative immunogenicity of 2 antirabies vaccines in a 2-1-1 post-exposure vaccination schedule].
    Landry P; Lazzaro M; Darioli R
    Praxis (Bern 1994); 1998 Sep; 87(37):1177-9. PubMed ID: 9785997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of 41 persons exposed to a rabid dog: unplanned experience with human diploid vaccine.
    Dempster G; Stead S; Zbitnew A; Rhodes AJ; Zalan E
    Can Med Assoc J; 1979 May; 120(9):1069-74. PubMed ID: 445300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pre-exposure rabies vaccination using a new duck embryo vaccine].
    Bachmann G; Steffen R; Glück R; Wegmann A; Schär M
    Schweiz Med Wochenschr; 1985 Jun; 115(25):863-5. PubMed ID: 4023675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rabies post-exposure prophylaxis with purified equine rabies immunoglobulin: one-year follow-up of patients with laboratory-confirmed category III rabies exposure in the Philippines.
    Quiambao BP; Dy-Tioco HZ; Dizon RM; Crisostomo ME; Teuwen DE
    Vaccine; 2009 Nov; 27(51):7162-6. PubMed ID: 19925947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of post-exposure rabies vaccination under the 2-1-1 regimen: a field trial in Indonesia. MAS054 Clinical Investigator Group.
    Lang J; Simanjuntak GH; Soerjosembodo S; Koesharyono C
    Bull World Health Organ; 1998; 76(5):491-5. PubMed ID: 9868840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical trial with an anti-rabies human diploid cell vaccine (HDCV).
    Gerichter CB; Shtark J; Braunstein I
    Dev Biol Stand; 1978; 41():241-4. PubMed ID: 381073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative study on the immunogenicity, safety and tolerance of purified duck embryo vaccine (PDEV) manufactured in India (Vaxirab) and Switzerland (Lyssavac-N): a randomized simulated post-exposure study in healthy volunteers.
    Mahendra BJ; Madhusudana SN; Ashwathnarayana DH; Sampath G; datta SS; Sudarshan MK; Venkatesh GM; Muhamuda K; Bilagumba G; Shamanna M
    Vaccine; 2007 Dec; 25(50):8405-9. PubMed ID: 17981377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies.
    Lang J; Gravenstein S; Briggs D; Miller B; Froeschle J; Dukes C; Le Mener V; Lutsch C
    Biologicals; 1998 Mar; 26(1):7-15. PubMed ID: 9637744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity and safety in adults of a new chromatographically purified Vero-cell rabies vaccine (CPRV): a randomized, double-blind trial with purified Vero-cell rabies vaccine (PVRV).
    Lang J; Cetre JC; Picot N; Lanta M; Briantais P; Vital S; Le Mener V; Lutsch C; Rotivel Y
    Biologicals; 1998 Dec; 26(4):299-308. PubMed ID: 10403033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroconversion following incomplete human rabies postexposure prophylaxis.
    Robertson K; Recuenco S; Niezgoda M; Garcia EJ; Rupprecht CE
    Vaccine; 2010 Sep; 28(39):6523-6. PubMed ID: 20637309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and evaluation of a competitive ELISA for estimation of rabies neutralizing antibodies after post-exposure rabies vaccination in humans.
    Muhamuda K; Madhusudana SN; Ravi V
    Int J Infect Dis; 2007 Sep; 11(5):441-5. PubMed ID: 17321182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of two intradermal vaccination regimens using purified chick embryo cell vaccine for post-exposure prophylaxis of rabies.
    Madhusudana SN; Anand NP; Shamsundar R
    Natl Med J India; 2001; 14(3):145-7. PubMed ID: 11467142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunogenicity of a new, highly purified, highly concentrated duck-embryo rabies vaccine].
    Keller H; Glück R; Wegmann A; Wandeler AI
    Schweiz Med Wochenschr; 1984 May; 114(19):648-53. PubMed ID: 6740281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.